Toll-like receptor agonists regulate β-defensin 2 release in hair follicle

被引:16
|
作者
Selleri, S.
Arnaboldi, F.
Palazzo, M.
Gariboldi, S.
Zanobbio, L.
Opizzi, E.
Shirai, Y. F.
Balsari, A.
Rumio, C.
机构
[1] Univ Milan, Dept Human Morphol, I-20133 Milan, Italy
[2] Univ Milan, Inst Pathol, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Mol Target Unit, I-20133 Milan, Italy
关键词
beta-defensin; 2; hair follicle; mouse; skin; toll-like receptor;
D O I
10.1111/j.1365-2133.2007.07899.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Skin is constantly in contact with different pathogens, which are present in the environment. The hair follicle is particularly susceptible to this microbial invasion as it offers an easy way of access for microorganisms; for this reason it is equipped with defence mechanisms to avoid frequent infections. Objectives To analyse the expression pattern of four different members of the toll-like receptor (TLR) family in murine hair follicles and to evaluate the effects of their activation by their specific microbiota-derived agonists, in terms of production of the antimicrobial peptide beta-defensin 2 (DEFB2). Methods TLR and DEFB2 protein expression was investigated by immunohistochemistry on murine skin samples. Results Murine hair follicle expresses TLR2, TLR4 and TLR5; agonists of TLR2, TLR4 and TLR5 but not of TLR9 induced DEFB2 production in this compartment. The strongest DEFB2 expression was observed following TLR4 activation by lipopolysaccharide. Conclusions Our data show that the hair follicle is equipped with TLR2, TLR4 and TLR5, and that these receptors are able to respond to microbial stimuli inducing the production of DEFB2 by epithelial cells. This immune response might be important in preserving the skin from microorganism infections.
引用
收藏
页码:1172 / 1177
页数:6
相关论文
共 50 条
  • [1] Airway epithelia regulate expression of human β-defensin 2 through toll-like receptor 2
    Wang, XR
    Zhang, Z
    Louboutin, JP
    Moser, C
    Weiner, DJ
    Wilson, JM
    FASEB JOURNAL, 2003, 17 (10): : 1727 - +
  • [2] Toll-like receptor agonists and cancer
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (07) : 511 - 511
  • [3] Radiotherapy and Toll-Like Receptor Agonists
    Marabelle, Aurelien
    Filatenkov, Alex
    Sagiv-Barfi, Idit
    Kohrt, Holbrook
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (01) : 34 - 39
  • [4] Toll-like receptor 7 agonists and skin
    Novak, Natalija
    Yu, Chun-Feng
    Bieber, Thomas
    Allam, Jean-Pierre
    DRUG NEWS & PERSPECTIVES, 2008, 21 (03) : 158 - 165
  • [5] Toll-Like Receptor Agonists Are They Good Adjuvants?
    Gnjatic, Sacha
    Sawhney, Nikhil B.
    Bhardwaj, Nina
    CANCER JOURNAL, 2010, 16 (04): : 382 - 391
  • [6] Toll-like receptor agonists in cancer therapy
    Adams, Sylvia
    IMMUNOTHERAPY, 2009, 1 (06) : 949 - 964
  • [7] Clinical investigations of Toll-like receptor agonists
    Meyer, Thomas
    Stockfleth, Eggert
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (07) : 1051 - 1065
  • [8] Antiviral applications of Toll-like receptor agonists
    Horscroft, Nigel J.
    Pryde, David C.
    Bright, Helen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 789 - 801
  • [9] Toll-like receptor agonists in oncological indications
    Aranda, Fernando
    Vacchelli, Erika
    Obrist, Florine
    Eggermont, Alexander
    Galon, Jerome
    Sautes-Fridman, Catherine
    Cremer, Isabelle
    ter Meulen, Jan Henrik
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2014, 3 (06):
  • [10] Toll-Like Receptor 9 Agonists in Cancer
    Karapetyan, Lilit
    Luke, Jason J.
    Davar, Diwakar
    ONCOTARGETS AND THERAPY, 2020, 13 : 10039 - 10060